In the AIP context, it attempted to re-establish glucose homeostasis by activating hepatic gluconeogenesis and increasing mitochondrial mass, but it also induced ALAS1 expression [12,13,17], thereby exacerbating the porphyrins’ overproduction. The gene discussed is ALAS1; the disease is autoimmune pancreatitis.